Columbus, OH – According to a press release from the Horseracing Integrity and Safety Authority on Friday (Jan. 27), “The Federal Trade Commission has published the resubmitted Horseracing Integrity and Safety Authority Anti-Doping and Medication Control rules to the Federal Register, initiating a 14-day public comment period. The FTC now has 60 days to approve or deny the proposed rules.”

“HISA’s draft ADMC rules were initially rejected by the FTC in late 2022 due to ongoing legal uncertainties.  HISA has resubmitted the rules for consideration by the FTC following a bipartisan act of Congress which addressed the constitutional questions raised by the Fifth Circuit Court of Appeals.

“Now that the rules have been resubmitted and posted to the Federal Register, HISA anticipates that its ADMC Program will go into effect March 27, 2023, pending FTC approval. The resubmitted rules include a small number of minor revisions from the version submitted in August 2022.  . A clean version of the proposed rules is available on the Federal Register now and a red-lined version will be available on HISA’s website within the next 48 hours.

“Included in the rules package are the Equine Anti-Doping and Controlled Medication Protocol, the Prohibited List, Definitions, Arbitration Procedures, Equine Testing and Investigation Standards, and Equine Standards for Laboratories and Accreditation.”

To read the complete press release from he Horseracing Integrity and Safety Authority, click here.